協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/13 | 2,707 | 2,749 | 2,682 | 2,744 | +64 | +2.4% | 487,400 |
2020/07/10 | 2,763 | 2,763 | 2,679 | 2,680 | -33 | -1.2% | 882,700 |
2020/07/09 | 2,716 | 2,725 | 2,669 | 2,713 | -4 | -0.1% | 539,400 |
2020/07/08 | 2,754 | 2,774 | 2,714 | 2,717 | -49 | -1.8% | 773,000 |
2020/07/07 | 2,775 | 2,783 | 2,727 | 2,766 | -26 | -0.9% | 867,400 |
2020/07/06 | 2,800 | 2,824 | 2,786 | 2,792 | -17 | -0.6% | 731,400 |
2020/07/03 | 2,751 | 2,810 | 2,750 | 2,809 | +84 | +3.1% | 638,400 |
2020/07/02 | 2,743 | 2,765 | 2,694 | 2,725 | -39 | -1.4% | 1,145,000 |
2020/07/01 | 2,850 | 2,850 | 2,735 | 2,764 | -65 | -2.3% | 710,000 |
2020/06/30 | 2,837 | 2,853 | 2,793 | 2,829 | +20 | +0.7% | 791,100 |
2020/06/29 | 2,849 | 2,894 | 2,807 | 2,809 | -90 | -3.1% | 647,200 |
2020/06/26 | 2,874 | 2,924 | 2,856 | 2,899 | +60 | +2.1% | 657,000 |
2020/06/25 | 2,822 | 2,861 | 2,785 | 2,839 | -10 | -0.4% | 671,400 |
2020/06/24 | 2,861 | 2,885 | 2,840 | 2,849 | -17 | -0.6% | 539,000 |
2020/06/23 | 2,900 | 2,904 | 2,810 | 2,866 | -23 | -0.8% | 684,500 |
2020/06/22 | 2,860 | 2,899 | 2,849 | 2,889 | +65 | +2.3% | 683,900 |
2020/06/19 | 2,870 | 2,885 | 2,820 | 2,824 | -26 | -0.9% | 1,445,000 |
2020/06/18 | 2,871 | 2,877 | 2,808 | 2,850 | -21 | -0.7% | 457,400 |
2020/06/17 | 2,881 | 2,886 | 2,847 | 2,871 | +2 | +0.1% | 621,100 |
2020/06/16 | 2,772 | 2,881 | 2,757 | 2,869 | +144 | +5.3% | 1,031,600 |
2020/06/15 | 2,740 | 2,822 | 2,722 | 2,725 | -55 | -2% | 697,900 |
2020/06/12 | 2,720 | 2,793 | 2,673 | 2,780 | +2 | +0.1% | 1,603,900 |
2020/06/11 | 2,808 | 2,816 | 2,769 | 2,778 | -51 | -1.8% | 1,464,400 |
2020/06/10 | 2,785 | 2,840 | 2,775 | 2,829 | +8 | +0.3% | 1,331,100 |
2020/06/09 | 2,822 | 2,834 | 2,805 | 2,821 | -30 | -1.1% | 1,300,600 |
2020/06/08 | 2,914 | 2,925 | 2,836 | 2,851 | -59 | -2% | 1,398,200 |
2020/06/05 | 2,962 | 2,969 | 2,889 | 2,910 | -53 | -1.8% | 1,236,800 |
2020/06/04 | 2,937 | 2,979 | 2,911 | 2,963 | +12 | +0.4% | 1,171,700 |
2020/06/03 | 3,010 | 3,025 | 2,936 | 2,951 | -23 | -0.8% | 1,045,300 |
2020/06/02 | 2,887 | 2,985 | 2,868 | 2,974 | +112 | +3.9% | 1,355,600 |
2020/06/01 | 2,900 | 2,901 | 2,850 | 2,862 | -60 | -2.1% | 1,429,100 |
2020/05/29 | 2,930 | 2,954 | 2,875 | 2,922 | +37 | +1.3% | 3,695,900 |
2020/05/28 | 2,861 | 2,885 | 2,808 | 2,885 | +46 | +1.6% | 1,027,000 |
2020/05/27 | 2,800 | 2,869 | 2,781 | 2,839 | +36 | +1.3% | 1,038,700 |
2020/05/26 | 2,798 | 2,851 | 2,790 | 2,803 | +29 | +1% | 1,172,800 |
2020/05/25 | 2,767 | 2,779 | 2,746 | 2,774 | +54 | +2% | 684,200 |
2020/05/22 | 2,701 | 2,733 | 2,680 | 2,720 | +29 | +1.1% | 962,700 |
2020/05/21 | 2,673 | 2,707 | 2,650 | 2,691 | +27 | +1% | 902,900 |
2020/05/20 | 2,621 | 2,676 | 2,605 | 2,664 | +43 | +1.6% | 723,000 |
2020/05/19 | 2,647 | 2,654 | 2,618 | 2,621 | -3 | -0.1% | 846,100 |
2020/05/18 | 2,607 | 2,640 | 2,602 | 2,624 | +41 | +1.6% | 627,600 |
2020/05/15 | 2,607 | 2,610 | 2,547 | 2,583 | +12 | +0.5% | 786,800 |
2020/05/14 | 2,618 | 2,636 | 2,565 | 2,571 | -44 | -1.7% | 724,500 |
2020/05/13 | 2,636 | 2,655 | 2,611 | 2,615 | +15 | +0.6% | 998,800 |
2020/05/12 | 2,587 | 2,621 | 2,563 | 2,600 | +18 | +0.7% | 665,200 |
2020/05/11 | 2,616 | 2,653 | 2,580 | 2,582 | -32 | -1.2% | 937,700 |
2020/05/08 | 2,640 | 2,650 | 2,599 | 2,614 | +46 | +1.8% | 1,892,600 |
2020/05/07 | 2,517 | 2,584 | 2,462 | 2,568 | +99 | +4% | 1,551,000 |
2020/05/01 | 2,511 | 2,530 | 2,431 | 2,469 | -49 | -1.9% | 1,493,000 |
2020/04/30 | 2,514 | 2,535 | 2,476 | 2,518 | +64 | +2.6% | 1,435,100 |
1251~
1300
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.65倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.01倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.19倍 | 1.61倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.56倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム